About Radison Labs Private Limited
Data last updated:
Radison Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2006PTC051910. Its GSTIN is 36AAKCS5352G1Z6 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹7.5 Cr. It was formerly known as Sahithi Drugs & Intermediates Private Limited. It is led by directors including Pathapati Venkata Satyanarayana Raju (Managing Director) and Venugopala Raju Dandu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹202.11 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹5.62 Cr (net margin 2.8%) and EBITDA of ₹13.48 Cr (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 34% over five years.
The company has about 133 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹53.18 Cr and satisfied charges of ₹31.38 Cr on record. The company has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹30.9 Lakh; the latest was in November 2023. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Kilitch Drugs (India) Limited. with revenue of ₹209.48 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website radisonlabs.com.
Company details
CIN history
Radison Labs has one previous CIN (Corporate Identification Number): U24232AP2006PTC051910. The current CIN is U24232TG2006PTC051910, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2006PTC051910 | Current |
| U24232AP2006PTC051910 | Previous |
Contact details
Radison Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is radisonlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.141 Flat No.201 Sri Sai Balaji Towers Above Canara Bank Mathrusri Nagar Miya, Pur, Hyderabad, Telangana, India – 500049
- IndustryPharma, API Manufacturers
To see the full contact details of Radison Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Radison Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Radison Labs Private Limited, buy the company report.
Financials of Radison Labs Private Limited
FY 2025 filings availableRadison Labs Private Limited reported revenue of ₹202.11 Cr (up 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 43% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Radison Labs Private Limited, buy the company report.
Board of directors of Radison Labs Private Limited
Radison Labs has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venugopala Raju Dandu Also directs: Sadanjana Pharma Private Limited | Director | 24 Feb 2014 | 12 Years 7 Months | Current |
| Pathapati Venkata Satyanarayana Raju Also directs: Rishon Laboratories Private Limited, Perkin Laboratories Private Limited, Sadanjana Pharma Private Limited and 1 more | Managing Director | 24 Feb 2014 | 12 Years 7 Months | Current |
| Pathapati Rajya Lakshmi | Director | 24 Feb 2014 | 12 Years 7 Months | Current |
Peer comparison
Radison Labs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kilitch Drugs (India) Limited. | ₹209.48 Cr (FY 2025) | 32.0% | Thane, Maharashtra, India | |||
| Biodeal Pharmaceuticals Limited | ₹209.4 Cr (FY 2025) | 46.0% | Nalagarh, Distt. Solan (Hp), Himachal Pradesh, India | |||
| Cheryl Laboratories Pvt Ltd | ₹206.58 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Radison Labs Private Limitedthis company | ₹202.11 Cr (FY 2025) | ₹5.62 Cr | 2.8% | 43.0% | 133 | Hyderabad, Telangana, India |
| Topnotch Chemicals Pvt Ltd | ₹201.92 Cr (FY 2024) | -14.0% | Navi Mumbai, Maharashtra, India | |||
| Finecure Pharmaceuticals Limited | ₹201.85 Cr (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| Astral Steritech Private Limited | ₹201.59 Cr (FY 2022) | -36.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Radison Labs Private Limited, buy the company report.
Auditor
Radison Labs Private Limited is audited by MSPR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSPR & CO | FY 2023 | 010152S |
Shareholding
The shareholding of Radison Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Radison Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jul 2025 | 101173153 | Hdfc Bank Limited | ₹23.55 Lakh | Open | |
| 30 Mar 2022 | 100589704 | Hdfc Bank Limited | ₹27.08 Lakh | Open | |
| 31 Jan 2022 | 100552175 | Others | ₹92.22 Lakh | Open | |
| 15 Jun 2020 | 100351180 | Hdfc Bank Limited | ₹51.75 Cr | Open | |
| 29 Jan 2019 | 100240372 | State Bank of India | ₹17 Cr | Satisfied |
To see the full charge records of Radison Labs Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Radison Labs Private Limited has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹30.9 Lakh; the latest was in November 2023.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2017 | Rights issue | ₹3.64 Cr | Investors: 4 individuals |
| Mar 2014 | Funding round | ₹30.9 Lakh | Investors: 4 individuals |
| Feb 2014 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Radison Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Radison Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Radison Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Radison Labs Private Limited has a workforce of 133 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Radison Labs has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCS5352G1Z6 | Telangana | Active | 01 Jul 2017 |
| 29AAKCS5352G1Z1 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Radison Labs Private Limited, buy the company report.
Recent activity
Radison Labs Private Limited has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Mohan Rama Subba Rao Gowthu ceased to be Director on 02 Nov 2023.
9 earlier events are in the company report.
Frequently asked questions
Radison Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 December 2006 (20+ years old) and is registered under CIN U24232TG2006PTC051910.
Radison Labs has 3 current directors:
- Pathapati Venkata Satyanarayana Raju - Managing Director
- Venugopala Raju Dandu - Director
- Pathapati Rajya Lakshmi - Director
The latest financial statements of Radison Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Radison Labs is 36AAKCS5352G1Z6, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAKCS5352G1Z1 (Karnataka).
The CIN (Corporate Identification Number) of Radison Labs is U24232TG2006PTC051910. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Radison Labs was incorporated on 05 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Radison Labs has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹30.9 Lakh; the latest was in November 2023.
The peers of Radison Labs by revenue are Kilitch Drugs (India) Limited, Biodeal Pharmaceuticals Limited, Cheryl Laboratories Pvt Ltd, Smilax Laboratories Limited, Topnotch Chemicals Pvt Ltd and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mohan Rama Subba Rao Gowthu ceased to be Director on 02 Nov 2023. Pathapati Venkata Satyanarayana Raju ceased to be Director on 01 Jan 2020. Prabhavathi Sallipala ceased to be Director on 25 Feb 2014. Radison Labs has 8 board changes on record in total.
Radison Labs can be reached through the website radisonlabs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Radison Labs is at Plot No.141 Flat No.201 Sri Sai Balaji Towers Above Canara Bank Mathrusri Nagar Miya, Pur, Hyderabad, Telangana, India – 500049.